TY - JOUR
T1 - Evaluation of 50 probands with early-onset Parkinson's disease for Parkin mutations
AU - Hedrich, K.
AU - Marder, K.
AU - Harris, J.
AU - Kann, M.
AU - Lynch, T.
AU - Meija-Santana, H.
AU - Pramstaller, P. P.
AU - Schwinger, E.
AU - Bressman, S. B.
AU - Fahn, S.
AU - Klein, C.
PY - 2002/4/23
Y1 - 2002/4/23
N2 - Background: Early onset PD has been associated with different mutations in the Parkin gene, including exon deletions and duplications. Methods: The authors performed an extensive mutational analysis on 50 probands with onset of PD at younger than 50 years of age. Thirteen probands were ascertained from a registry of familial PD and 37 probands by age at onset at younger than 50 years, blind to family history. Mutational analysis was undertaken on the probands and available family members and included conventional techniques (single strand conformation polymorphism analysis and sequencing) and a newly developed method of quantitative duplex PCR to detect alterations of gene dosage (exon deletions and duplications) in Parkin. Results: Using this new technique, the authors detected eight alterations of gene dosage in the probands, whereas 12 mutations were found by conventional methods among the probands and another different mutation in an affected family member. In total, the authors identified compound heterozygous mutations in 14%, heterozygous mutations in 12%, and no Parkin mutation in 74% of the 50 probands. We expanded the occurrence of Parkin mutations to another ethnic group (African-American). Conclusion: The authors systematically screened all 12 Parkin exons by quantitative PCR and conventional methods in 50 probands. Eight mutations were newly reported, 2 of which are localized in exon 1, and 38% of the mutations were gene dosage alterations. These results underline the need to screen all exons and to undertake gene dosage studies. Furthermore, this study reveals a frequency of heterozygous mutation carriers that may signify a unique mode of inheritance and expression of the Parkin gene.
AB - Background: Early onset PD has been associated with different mutations in the Parkin gene, including exon deletions and duplications. Methods: The authors performed an extensive mutational analysis on 50 probands with onset of PD at younger than 50 years of age. Thirteen probands were ascertained from a registry of familial PD and 37 probands by age at onset at younger than 50 years, blind to family history. Mutational analysis was undertaken on the probands and available family members and included conventional techniques (single strand conformation polymorphism analysis and sequencing) and a newly developed method of quantitative duplex PCR to detect alterations of gene dosage (exon deletions and duplications) in Parkin. Results: Using this new technique, the authors detected eight alterations of gene dosage in the probands, whereas 12 mutations were found by conventional methods among the probands and another different mutation in an affected family member. In total, the authors identified compound heterozygous mutations in 14%, heterozygous mutations in 12%, and no Parkin mutation in 74% of the 50 probands. We expanded the occurrence of Parkin mutations to another ethnic group (African-American). Conclusion: The authors systematically screened all 12 Parkin exons by quantitative PCR and conventional methods in 50 probands. Eight mutations were newly reported, 2 of which are localized in exon 1, and 38% of the mutations were gene dosage alterations. These results underline the need to screen all exons and to undertake gene dosage studies. Furthermore, this study reveals a frequency of heterozygous mutation carriers that may signify a unique mode of inheritance and expression of the Parkin gene.
UR - http://www.scopus.com/inward/record.url?scp=0037161261&partnerID=8YFLogxK
U2 - 10.1212/WNL.58.8.1239
DO - 10.1212/WNL.58.8.1239
M3 - Journal articles
C2 - 11971093
AN - SCOPUS:0037161261
SN - 0028-3878
VL - 58
SP - 1239
EP - 1246
JO - Neurology
JF - Neurology
IS - 8
ER -